NKCx Histopathological outcome* within 12 months after cervix cytology in 2018
088 (081) Huddinge

  Benign CIN1 CIN2 CIN3 AIS Cancer Other PAD missing Total
Cytology Count Pct Count Pct Count Pct Count Pct Antal Andel Count Pct Count Pct Count Pct Count Pct
Benign sample 464 1.5% 255 0.8% 8 0.0% 116 0.4% 4 0.0% 4 0.0% 62 0.2% 29568 97.0% 30481 100.0%
ASCUS 364 24.0% 373 24.6% 4 0.3% 263 17.3% 5 0.3% 1 0.1% 74 4.9% 434 28.6% 1518 100.0%
CIN1 411 24.3% 567 33.5% 20 1.2% 337 19.9% 3 0.2% . . 56 3.3% 300 17.7% 1694 100.0%
Atypical glandular cells/AGC 12 10.9% 29 26.4% . . 47 42.7% 7 6.4% 9 8.2% 2 1.8% 4 3.6% 110 100.0%
Unclear atypia 5 41.7% 3 25.0% . . 3 25.0% . . . . . . 1 8.3% 12 100.0%
ASC-H 27 11.3% 36 15.1% 5 2.1% 149 62.3% 2 0.8% 5 2.1% 11 4.6% 4 1.7% 239 100.0%
CIN3 83 7.8% 90 8.5% 8 0.8% 833 78.3% 12 1.1% 12 1.1% 12 1.1% 14 1.3% 1064 100.0%
Adenocarcinoma 1 2.2% 5 10.9% . . 12 26.1% 13 28.3% 15 32.6% . . . . 46 100.0%
Squamous cell cancer . . 1 5.0% . . 16 80.0% . . 2 10.0% . . 1 5.0% 20 100.0%
Total 1367 3.9% 1359 3.9% 45 0.1% 1776 5.0% 46 0.1% 48 0.1% 217 0.6% 30326 86.2% 35184 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the category Cancer:
M80001, M80413, M80703, M81401, M81403, M83803